The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHon Hai Precsn Regulatory News (HHPD)

Share Price Information for Hon Hai Precsn (HHPD)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 9.55
Bid: 9.53
Ask: 9.57
Change: 0.09 (0.95%)
Spread: 0.04 (0.42%)
Open: 9.53
High: 9.62
Low: 9.50
Prev. Close: 9.46
HHPD Live PriceLast checked at -
  • This share is an international stock.

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

2018 4th IFRS Consolidated Financial Statements

1 Apr 2019 13:05

RNS Number : 7000U
Hon Hai Precision Industry Co Ld
01 April 2019
 

HON HAI PRECISION INDUSTRY CO., LTD. AND SUBSIDIARIES CONSOLIDATED SHEETS

2018 4th IFRS Consolidated Financial Statements

 

 

Balance Sheet

Accounting Title

2018/12/31

2017/12/31

Balance Sheet

  Assets

Current assets

Cash and cash equivalents

788,662,325

642,496,059

Current financial assets at fair value through profit or loss

5,016,365

7,009,541

Current available-for-sale financial assets

0

290

Current financial assets at amortised cost

78,944,139

0

Accounts receivable, net

1,009,364,152

1,150,428,069

Accounts receivable due from related parties, net

48,172,268

80,066,388

Other receivables

73,996,367

67,700,725

Other receivables due from related parties

57,705,076

82,627,493

Current inventories

625,025,794

560,954,855

Prepayments

19,596,260

20,328,111

Other current assets

0

134,524,586

Total current assets

2,706,482,746

2,746,136,117

Non-current assets

Non-current financial assets at fair value through profit or loss

74,887,490

3,040,601

Non-current financial assets at fair value through other comprehensive income

66,634,395

0

Non-current available-for-sale financial assets

0

70,868,132

Non-current financial assets at amortised cost

16,240,740

0

Non-current financial assets at cost

0

49,861,639

Non-current investments in debt instrument without active market

0

4,571,100

Investments accounted for using equity method

160,316,664

151,000,283

Property, plant and equipment

277,860,012

278,204,005

Investment property, net

2,523,963

2,422,523

Intangible assets

30,357,025

9,552,444

Deferred tax assets

16,229,304

15,048,377

Other non-current assets

29,823,088

76,511,392

Total non-current assets

674,872,681

661,080,496

Total assets

3,381,355,427

3,407,216,613

  Liabilities and equity

Liabilities

Current liabilities

Current borrowings

532,315,377

418,835,146

Short-term notes and bills payable

19,283,228

10,960,269

Current financial liabilities at fair value through profit or loss

651,426

6,486,348

Accounts payable

905,682,505

1,119,169,644

Accounts payable to related parties

42,340,749

97,315,119

Other payables

228,985,231

255,696,126

Current tax liabilities

36,400,157

38,439,140

Current provisions

5,652,147

4,796,498

Other current liabilities

38,550,736

73,803,977

Total current liabilities

1,809,861,556

2,025,502,267

Non-current liabilities

Non-current financial liabilities at fair value through profit or loss

22,835

0

Bonds payable

178,794,577

168,495,189

Non-current portion of non-current borrowings

36,483,791

19,984,818

Deferred tax liabilities

14,649,508

12,541,548

Other non-current liabilities

9,109,272

8,900,336

Total non-current liabilities

239,059,983

209,921,891

Total liabilities

2,048,921,539

2,235,424,158

Equity

Equity attributable to owners of parent

Share capital

Ordinary share

138,629,906

173,287,383

Total capital stock

138,629,906

173,287,383

Capital surplus

Capital surplus, additional paid-in capital

88,501,031

88,501,031

Capital Surplus, changes in ownership interests in subsidiaries

88,873,887

3,300,393

Capital surplus, donated assets received

0

0

Capital surplus, changes in equity of associates and joint ventures accounted for using equity method

11,544,285

4,972,207

Capital surplus, employee share options

0

0

Capital surplus, share options

1,099,253

1,099,253

Capital Surplus, restricted stock

0

0

Capital surplus, others

0

0

Total capital surplus

190,018,456

97,872,884

Retained earnings

Legal reserve

136,606,364

122,732,924

Special reserve

27,539,310

0

Unappropriated retained earnings (accumulated deficit)

779,409,554

717,885,835

Total retained earnings

943,555,228

840,618,759

Other equity interest

Exchange differences on translation of foreign financial statements

-65,399,183

-56,320,437

Unrealised gains (losses) from financial assets measured at fair value through other comprehensive income

5,089,256

0

Unrealized gains (losses) on available-for-sale financial assets

0

28,781,127

Other equity, others

0

0

Total other equity interest

-60,309,927

-27,539,310

Treasury shares

15,194

18,901

Total equity attributable to owners of parent

1,211,878,469

1,084,220,815

Non-controlling interests

120,555,419

87,571,640

Total equity

1,332,433,888

1,171,792,455

Total liabilities and equity

3,381,355,427

3,407,216,613

Number of share capital awaiting retirement

0

0

Equivalent issue shares of advance receipts for ordinary share

0

0

Number of shares in entity held by entity and by its subsidiaries

1,483,078

1,853,848

 

Income Statement

 

Accounting Title

2018/4th

2017/4th

Statement of comprehensive income

  Operating revenue

Total operating revenue

5,293,803,022

4,706,736,096

  Operating costs

Total operating costs

4,961,773,118

4,403,729,149

  Gross profit (loss) from operations

332,029,904

303,006,947

  Gross profit (loss) from operations

332,029,904

303,006,947

  Operating expenses

Selling expenses

32,690,093

29,501,197

Administrative expenses

78,762,853

79,154,165

Research and development expenses

84,430,083

81,781,154

Total operating expenses

195,883,029

190,436,516

  Net operating income (loss)

136,146,875

112,570,431

  Non-operating income and expenses

Other income

Total other income

74,415,499

52,830,252

Other gains and losses

Other gains and losses, net

-997,809

45,649,591

Finance costs

Finance costs, net

55,544,836

38,994,404

Share of profit (loss) of associates and joint ventures accounted for using equity method

Share of profit (loss) of associates and joint ventures accounted for using equity method, net

16,231,713

10,816,753

Total non-operating income and expenses

34,104,567

70,302,192

  Profit (loss) from continuing operations before tax

170,251,442

182,872,623

  Tax expense (income)

Total tax expense (income)

40,416,017

47,498,095

  Profit (loss) from continuing operations

129,835,425

135,374,528

  Profit (loss)

129,835,425

135,374,528

  Other comprehensive income

Components of other comprehensive income that will not be reclassified to profit or loss

Gains (losses) on remeasurements of defined benefit plans

217,476

-54,572

Unrealised gains (losses) from investments in equity instruments measured at fair value through other comprehensive income

-4,687,419

0

Share of other comprehensive income of associates and joint ventures accounted for using equity method, components of other comprehensive income that will not be reclassified to profit or loss

-12,700,347

0

Income tax related to components of other comprehensive income that will not be reclassified to profit or loss

43,495

-9,277

Components of other comprehensive income that will not be reclassified to profit or loss

-17,213,785

-45,295

Components of other comprehensive income that will be reclassified to profit or loss

Exchange differences on translation

-11,603,077

-47,527,350

Unrealised gains (losses) on valuation of available-for-sale financial assets

0

-19,885,300

Share of other comprehensive income of associates and joint ventures accounted for using equity method, components of other comprehensive income that will be reclassified to profit or loss

-121,619

4,873,253

Income tax related to components of other comprehensive income that will be reclassified to profit or loss

0

-6,192,134

Components of other comprehensive income that will be reclassified to profit or loss

-11,724,696

-56,347,263

Other comprehensive income, net

-28,938,481

-56,392,558

  Total comprehensive income

100,896,944

78,981,970

  Profit (loss), attributable to:

Profit (loss), attributable to owners of parent

129,065,105

138,734,401

Profit (loss), attributable to non-controlling interests

770,320

-3,359,873

  Comprehensive income attributable to:

Comprehensive income, attributable to owners of parent

103,120,437

78,641,529

Comprehensive income, attributable to non-controlling interests

-2,223,493

340,441

  Basic earnings per share

Basic earnings (loss) per share from continuing operations

8.03

8.01

Total basic earnings per share

8.03

8.01

  Diluted earnings per share

Diluted earnings (loss) per share from continuing operations

7.95

7.91

Total diluted earnings per share

7.95

7.91

 

 

Statements of Cash Flows

Accounting Title

2018/4th

2017/4th

Statement of cash flows

  Cash flows from (used in) operating activities, indirect method

Profit (loss) from continuing operations before tax

170,251,442

182,872,623

Profit (loss) before tax

170,251,442

182,872,623

Adjustments

Adjustments to reconcile profit (loss)

Depreciation expense

58,210,706

59,736,585

Amortization expense

1,715,151

1,263,825

Expected credit loss (gain) / Provision (reversal of provision) for bad debt expense

195,147

2,056,114

Net loss (gain) on financial assets or liabilities at fair value through profit or loss

-12,202,000

21,402,244

Interest expense

54,978,871

38,742,136

Interest income

-60,400,627

-46,305,757

Dividend income

-3,543,981

-1,202,077

Share of loss (profit) of associates and joint ventures accounted for using equity method

-16,231,713

-10,816,753

Loss (gain) on disposal of property, plan and equipment

824,918

22,420

Loss (gain) on disposal of investments

-1,666,502

-66,182,488

Impairment loss on financial assets

2,535,426

6,542,022

Impairment loss on non-financial assets

2,589,522

0

Total adjustments to reconcile profit (loss)

27,004,918

5,258,271

Changes in operating assets and liabilities

Changes in operating assets

Decrease (increase) in financial assets held for trading

0

-6,191,988

Decrease (increase) in financial assets at fair value through profit or loss, mandatorily measured at fair value

-2,011,528

0

Decrease (increase) in notes receivable

-302,417

33,912

Decrease (increase) in accounts receivable

143,814,705

-449,242,401

Decrease (increase) in accounts receivable due from related parties

31,879,664

-51,527,913

Decrease (increase) in other receivable

2,888,426

-30,688,932

Decrease (increase) in inventories

-58,738,438

-173,680,794

Decrease (increase) in prepayments

731,851

-7,242,608

Total changes in operating assets

118,262,263

-718,540,724

Changes in operating liabilities

Increase (decrease) in accounts payable

-220,012,620

440,114,387

Increase (decrease) in accounts payable to related parties

-54,974,370

66,707,190

Increase (decrease) in other payable

-37,530,727

24,668,730

Increase (decrease) in provisions

855,649

1,813,462

Increase (decrease) in other current liabilities

-1,747,794

-2,164,466

Increase (decrease) in net defined benefit liability

-123,752

-26,561

Total changes in operating liabilities

-313,533,614

531,112,742

Total changes in operating assets and liabilities

-195,271,351

-187,427,982

Total adjustments

-168,266,433

-182,169,711

Cash inflow (outflow) generated from operations

1,985,009

702,912

Income taxes refund (paid)

-42,141,231

-40,044,225

  Net cash flows from (used in) operating activities

-40,156,222

-39,341,313

  Cash flows from (used in) investing activities

Acquisition of financial assets at fair value through other comprehensive income

-7,514,778

0

Proceeds from disposal of financial assets at fair value through other comprehensive income

2,794,477

0

Acquisition of financial assets at amortised cost

-14,312,960

0

Proceeds from disposal of financial assets at amortised cost

55,580,447

0

Proceeds from repayments of financial assets at amortised cost

1,379,850

0

Acquisition of financial assets at fair value through profit or loss

-4,405,425

-10,679,250

Proceeds from disposal of financial assets at fair value through profit or loss

112,953

0

Acquisition of available-for-sale financial assets

0

-154,752

Proceeds from disposal of available-for-sale financial assets

0

4,232,224

Acquisition of investments in debt instrument without active market

0

-4,571,100

Acquisition of financial assets at cost

0

-26,843,966

Proceeds from disposal of financial assets at cost

0

1,354,203

Acquisition of investments accounted for using equity method

-3,937,967

-731,379

Net cash flow from acquisition of subsidiaries

-26,112,000

0

Proceeds from capital reduction of investments accounted for using equity method

0

964,799

Acquisition of property, plant and equipment

-65,532,812

-60,384,846

Proceeds from disposal of property, plant and equipment

27,883,428

9,994,734

Decrease in other receivables due from related parties

44,992,310

330,498

Increase in other financial assets

0

-27,776,193

Increase in other non-current assets

-167,081

0

Decrease in other non-current assets

0

757,069

Increase in other prepayments

0

-545,816

Decrease in other prepayments

241,377

0

Interest received

54,451,751

43,690,301

Dividends received

6,290,869

5,464,796

Other investing activities

-312,983

-92,074

Net cash flows from (used in) investing activities

71,431,456

-64,990,752

  Cash flows from (used in) financing activities

Increase in short-term loans

113,480,231

247,363,003

Increase in short-term notes and bills payable

8,340,928

0

Decrease in short-term notes and bills payable

0

-5,030,000

Proceeds from issuing bonds

19,500,000

54,202,207

Repayments of bonds

-38,617,729

-58,589,080

Proceeds from long-term debt

17,585,680

12,896,069

Repayments of long-term debt

-7,440,627

-9,159,975

Increase in other non-current liabilities

645,671

367,786

Cash dividends paid

-34,657,477

-77,979,322

Capital reduction payments to shareholders

-34,653,770

0

Interest paid

-48,346,530

-34,839,842

Change in non-controlling interests

251,608

17,009,053

Other financing activities

122,882,261

0

Net cash flows from (used in) financing activities

118,970,246

146,239,899

  Effect of exchange rate changes on cash and cash equivalents

-4,079,214

-32,567,076

  Net increase (decrease) in cash and cash equivalents

146,166,266

9,340,758

  Cash and cash equivalents at beginning of period

642,496,059

633,155,301

  Cash and cash equivalents at end of period

788,662,325

642,496,059

Cash and cash equivalents reported in the statement of financial position

788,662,325

642,496,059

Statements of Changes in Stockholders' Equity

Ordinary share

Total share capital

Capital surplus

Legal reserve

Special reserve

Unappropriated retained earnings (accumulated deficit)

Total retained earnings

Exchange differences on translation of foreign financial statements

Unrealised gains (losses) on financial assets measured at fair value through other comprehensive income

Unrealized gains (losses) on available-for-sale financial assets

Total other equity interest

Treasury shares

Total equity attributable to owners of parent

Non-controlling interests

Total equity

Equity

173,287,383

173,287,383

97,872,884

122,732,924

0

717,885,835

840,618,759

-56,320,437

0

28,781,127

-27,539,310

-18,901

1,084,220,815

87,571,640

1,171,792,455

Effects of retrospective application and retrospective restatement

0

0

0

0

0

7,309,666

7,309,666

0

23,174,353

-28,781,127

-5,606,774

0

1,702,892

-297,228

1,405,664

Equity at beginning of period after adjustments

173,287,383

173,287,383

97,872,884

122,732,924

0

725,195,501

847,928,425

-56,320,437

23,174,353

0

-33,146,084

-18,901

1,085,923,707

87,274,412

1,173,198,119

Legal reserve appropriated

0

0

0

13,873,440

0

-13,873,440

0

0

0

0

0

0

0

0

0

Special reserve appropriated

0

0

0

0

27,539,310

-27,539,310

0

0

0

0

0

0

0

0

0

Cash dividends of ordinary share

0

0

0

0

0

-34,657,477

-34,657,477

0

0

0

0

0

-34,657,477

0

-34,657,477

Changes in equity of associates and joint ventures accounted for using equity method

0

0

6,572,078

0

0

0

0

0

0

0

0

0

6,572,078

0

6,572,078

Profit (loss)

0

0

0

0

0

129,065,105

129,065,105

0

0

0

0

0

129,065,105

770,320

129,835,425

Other comprehensive income

0

0

0

0

0

173,981

173,981

-9,078,746

-17,039,903

0

-26,118,649

0

-25,944,668

-2,993,813

-28,938,481

Total comprehensive income

0

0

0

0

0

129,239,086

129,239,086

-9,078,746

-17,039,903

0

-26,118,649

0

103,120,437

-2,223,493

100,896,944

Capital reduction

-34,657,477

-34,657,477

0

0

0

0

0

0

0

0

0

3,707

-34,653,770

0

-34,653,770

Changes in ownership interests in subsidiaries

0

0

85,573,494

0

0

0

0

0

0

0

0

0

85,573,494

251,608

85,825,102

Changes in non-controlling interests

0

0

0

0

0

0

0

0

0

0

0

0

0

35,252,892

35,252,892

Disposal of investments in equity instruments designated at fair value through other comprehensive income

0

0

0

0

0

1,045,194

1,045,194

0

-1,045,194

0

-1,045,194

0

0

0

0

Increase (decrease) in equity

-34,657,477

-34,657,477

92,145,572

13,873,440

27,539,310

54,214,053

95,626,803

-9,078,746

-18,085,097

0

-27,163,843

3,707

125,954,762

33,281,007

159,235,769

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
FR BBGDSRUGBGCB
Date   Source Headline
5th Feb 20219:55 amRNSSubsidiary Icreate obtaining Sinovation Fund L.P.
4th Feb 20218:24 amRNSUn-Audited Monthly Sales Ended January 31, 2021
4th Feb 20217:42 amRNSSubsidiary, Hongfujin (Tianjin) obtaining Shares
1st Feb 20218:27 amRNSSubsidiary obtaining shares
19th Jan 202110:27 amRNSSubsidiary disposal and obtaining of equipment
19th Jan 202110:15 amRNSSubsidiary obtaining HeNan FuChi shares
18th Jan 20219:45 amRNSSubsidiary obtaining shares
13th Jan 20219:10 amRNSFoxconn to sign a agreement with Zhejiang Geely
5th Jan 20219:00 amRNSUn-Audited Monthly Sales Ended December 31, 2020
31st Dec 202010:18 amRNSSubsidiary,FII announces Resignation of supervisor
31st Dec 202010:05 amRNSSubsidiary obtaining shares
31st Dec 20209:57 amRNSObtaining Yuzhan and FuTaiHua (ZhengZhou) shares
30th Dec 202010:25 amRNSSubsidiary obtaining TMJ Technology Shares
30th Dec 202010:22 amRNSSubsidiary obtaining System (Hai Ning) Shares
29th Dec 20207:00 amRNS3rd Unsecured Corporate Bonds Issuance in 2020
29th Dec 20207:00 amRNSSubsidiary disposal & obtaining of equipment
29th Dec 20207:00 amRNSFoxtron and DEPO Forms Strategic collaboration
24th Dec 20209:57 amRNSSubsidiary obtaining JUSDA INTERNATIONAL shares
24th Dec 20209:54 amRNSSubsidiary obtaining Shanghai Topone shares
16th Dec 20209:40 amRNSSubsidiary distribution of cash & stock dividends
11th Dec 20209:56 amRNSSubsidiary obtaining AchernarTek Inc. Shares
8th Dec 202010:03 amRNSExplain media reporting
3rd Dec 202011:04 amRNSUn-Audited Monthly Sales Ended November 30, 2020
27th Nov 202010:10 amRNSSubsidiary HongFuJin(ZhengZhou) disposal of road
24th Nov 20209:39 amRNSSubsidiary obtaining FuKang Technology Shares
13th Nov 20209:17 amRNS2020 3rd Quarter Results
12th Nov 202010:52 amRNSMerger involves Mainland China Subsidiaries
9th Nov 202010:07 amRNSSubsidiary obtaining Hongfucheng (Tianjin) shares
5th Nov 20208:49 amRNSUn-Audited Monthly Sales Ended October 31, 2020
30th Oct 20209:41 amRNSSubsidiary FII obtaining HongFuJin(TianJin) Shares
29th Oct 20208:21 amRNSInvestor Conference on FY20 3Q Financial Results
28th Oct 202010:36 amRNSExplain media reporting
22nd Oct 20207:00 amRNSSubsidiary disposal Alibaba Group Holding shares
21st Oct 20207:00 amRNSThe corporate bond pricing on subsidiary FFE-CY
9th Oct 202011:26 amRNSSubsidiary disposal Alibaba Group Holding shares
5th Oct 202010:33 amRNSUn-Audited Monthly Sales Ended September 30, 2020
28th Sep 202011:52 amRNSHON HAI and YAGEO Forms Strategic Alliance
28th Sep 202011:43 amRNSSubsidiary obtaining Foxsemicon Integrated shares
23rd Sep 202010:46 amRNSSubsidiary obtaining Nanjing Hongfusharp Shares
11th Sep 20204:41 pmRNSSecond Price Monitoring Extn
11th Sep 20204:35 pmRNSPrice Monitoring Extension
10th Sep 202010:47 amRNSSubsidiary obtaining HongFuTai (YanTai) Shares
8th Sep 20207:29 amRNS2nd Unsecured Corporate Bonds Issue in 2020
7th Sep 202010:43 amRNSUn-Audited Monthly Sales Ended August 31, 2020
4th Sep 20202:29 pmRNSShare swap by using Hon Hai's APT stocks with FET
2nd Sep 20202:45 pmRNSExplain media reporting
28th Aug 202010:53 amRNSSubsidiary, FFE-CY announce of cash dividend
13th Aug 202012:25 pmRNSExplain media reporting
12th Aug 20201:06 pmRNS2020 2nd Quarter Results
12th Aug 202012:12 pmRNSBOD approved the issue of unsecured corporate bond

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.